Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$40.97 - $43.33 $1,392 - $1,473
-34 Reduced 0.84%
4,030 $170,000
Q4 2023

Feb 13, 2024

SELL
$32.77 - $42.31 $557 - $719
-17 Reduced 0.42%
4,064 $169,000
Q3 2023

Nov 13, 2023

BUY
$35.46 - $40.13 $5,141 - $5,818
145 Added 3.68%
4,081 $153,000
Q2 2023

Aug 04, 2023

BUY
$24.24 - $40.97 $95,408 - $161,257
3,936 New
3,936 $149,000
Q4 2017

Feb 09, 2018

SELL
$104.5 - $126.38 $169,185 - $204,609
-1,619 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$97.26 - $116.2 $157,463 - $188,127
1,619
1,619 $182,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.